Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 6, 2025

Sensitivity evaluation to EZH2 inhibitors and EZH2 functional analysis in endometrial cancer cell lines

View Full Paper
Ask AI
Bookmark
Share

Authors

TOTakafumi OnishiHNHiroshi NiimiAKAya Kumazaki

Discussion

Loading...

Member takes

Overview

This investigation shows sensitivity to EZH2 inhibitors in endometrial cancer cell lines, indicating EZH2's role as a potential therapeutic target.

Key Points

  • EZH2 overexpression correlates with increased sensitivity to EZH2 inhibitors in endometrial cancer cell lines.
  • Cells with high EZH2 expression reacted more strongly to GSK126, one of the evaluated inhibitors.
  • Western blotting and immunocytochemistry confirmed variable EZH2 expression across different cell lines.
  • Data suggest targeting EZH2 may enhance personalized treatment strategies for endometrial cancer patients.

Cite This Study

Onishi et al. (2025) studied this question.

synapsesocial.com/papers/689a0f99e6551bb0af8d15c8https://doi.org/10.21203/rs.3.rs-7228876/v1
View Full Paper
Ask AI
Bookmark
Share